Millennium Management’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Millennium Management’s Portfolio NAVB Stock Details NAVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-128,756	Closed	-$33K	–	7143
2023 Q1	$33K	Buy	+128,756	New	+$37.6K	﹤0.01%	5750
2022 Q4	–	Sell	-40,146	Closed	-$10K	–	7787
2022 Q3	$10K	Buy	+40,146	New	+$18.7K	﹤0.01%	6682
2019 Q1	–	Sell	-981	Closed	-$2K	–	4521
2018 Q4	$2K	Buy	+981	New	+$4.04K	﹤0.01%	3693
2017 Q4	–	Sell	-2,971	Closed	-$25K	–	4256
2017 Q3	$25K	Sell	2,971 -12,293	-81%	-$104K	﹤0.01%	3440
2017 Q2	$156K	Sell	15,264 -10,290	-40%	-$102K	﹤0.01%	3245
2017 Q1	$295K	Sell	25,554 -16,540	-39%	-$188K	﹤0.01%	3052
2016 Q4	$529K	Sell	42,094 -7,519	-15%	-$119K	﹤0.01%	2653
2016 Q3	$908K	Sell	49,613 -18,512	-27%	-$234K	﹤0.01%	2322
2016 Q2	$723K	Buy	+68,125	New	+$1.34M	﹤0.01%	2316
2016 Q1	–	Sell	-3,968	Closed	-$106K	–	3846
2015 Q4	$106K	Buy	+3,968	New	+$138K	﹤0.01%	3234
2015 Q1	–	Sell	-1,360	Closed	-$51K	–	4332
2014 Q4	$51K	Buy	+1,360	New	+$37.4K	﹤0.01%	3829
2014 Q3	–	Sell	-1,705	Closed	-$50K	–	4162
2014 Q2	$50K	Buy	+1,705	New	+$55.1K	﹤0.01%	3307
2013 Q4	–	Sell	-1,361	Closed	-$72K	–	3936
2013 Q3	$72K	Buy	1,361 +396	+41%	+$23.1K	﹤0.01%	3205
2013 Q2	$52K	Buy	+965	New	+$48.2K	﹤0.01%	2910

Other funds holding NAVB

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACM

Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PFO

Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return

Millennium Management's NAVB Position: Q2 2023 in Review

Millennium Management sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q2 2023, closing a stake of 128,756 shares — an estimated $33K sold.

Millennium Management first reported a position in NAVB in Q2 2013 and held it in 14 quarters. The position peaked at $908K in Q3 2016. 23 funds tracked by Wall St. Rank hold NAVB as of Q2 2023.

Millennium Management reported no remaining Navidea Biopharmaceuticals Inc. position as of Q2 2023 after selling out during the quarter.
Millennium Management sold 128,756 Navidea Biopharmaceuticals Inc. shares in Q2 2023, an estimated $33K.
Millennium Management first reported a position in Navidea Biopharmaceuticals Inc. in Q2 2013 and held it in 14 quarters.
Millennium Management's Navidea Biopharmaceuticals Inc. position peaked at $908K in Q3 2016.
23 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q2 2023.

Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.